Council of State and Territorial Epidemiologists
VIII. Period of Surveillance
Download 356.89 Kb.
|
- Navigate this page:
- XI. Coordination Agencies for Response
- Agencies for Information: (Complete contact information must be provided for acceptance to review.)
- XII. Submitting Author: (Must be an Active CSTE Member and complete contact information provided for acceptance to review.)
- Co-Author: (Complete contact information must be provided for acceptance to review.)
- Table VI-B. Table of criteria to determine whether a case should be reported to public health authorities.
- Table VII-B. Criteria for defining a case of [ condition ].
- ICD-9-CM Diagnosis Code and Injury Cause E-Codes Explicitly Involving or Inclusive of Carbon Monoxide (CO) Poisoning Type
- ICD-10-CM Codes Explicitly Involving or Inclusive of Carbon Monoxide (CO) Poisoning Type Maine
- ICD-10 Cause of Death Codes Explicitly Involving or Inclusive of Carbon Monoxide (CO) Poisoning Type
VIII. Period of Surveillance Indicate whether surveillance is expected to be on-going or limited to a specific time period. On-going.
As appropriate, describe:
Notification of cases to CDC is recommended via the American Association of Poison Control Center’s (AAPCC) National Poison Data System (NPDS). There are no plans for the re-release of case data as the data are owned by AAPCC. Requests for case data should be to AAPCC. CDC plans to conduct standard periodic analysis of NPDS data and may conduct ad-hoc analyses as a part of disaster response activities. Aggregate case data will be incorporated into presentations, the CDC website, or publications such as MMWR. CDC may share results of ad-hoc analyses conducted after disasters if requested by the impacted states. X. References Where appropriate, include references to prior CSTE position statements. 1. Centers for Disease Control and Prevention (CDC). Nonfatal, unintentional, non--fire-related carbon monoxide exposures--United States, 2004-2006. MMWR Morb Mortal Wkly Rep. 2008 Aug 22;57(33):896-9. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5733a2.htm 2. Centers for Disease Control and Prevention (CDC). Carbon monoxide--related deaths--United States, 1999-2004. MMWR Morb Mortal Wkly Rep. 2007 Dec 21;56(50):1309-12. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5650a1.htm 3. Centers for Disease Control and Prevention (CDC). Carbon monoxide exposures--United States, 2000-2009. MMWR Morb Mortal Wkly Rep. 2011 Aug 5;60(30):1014-7. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6030a2.htm 4. Centers for Disease Control and Prevention (CDC). Monitoring poison control center data to detect health hazards during hurricane season--Florida, 2003-2005. MMWR Morb Mortal Wkly Rep. 2006 Apr 21;55(15):426-8. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5515a2.htm 5. Lutterloh EC, Iqbal S, Clower JH, Spiller HA, Riggs MA, Sugg TJ, Humbaugh KE, Cadwell BL, Thoroughman DA. Carbon monoxide poisoning after an ice storm in Kentucky, 2009. Public Health Rep. 2011 May-Jun;126 Suppl 1:108-15. http://www.publichealthreports.org/issueopen.cfm?articleID=2651 6. Centers for Disease Control and Prevention (CDC). Carbon monoxide exposures after hurricane Ike - Texas, September 2008. MMWR Morb Mortal Wkly Rep. 2009 Aug 14;58(31):845-9. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5831a1.htm 7. Centers for Disease Control and Prevention (CDC). Notes from the field: carbon monoxide exposures reported to poison centers and related to hurricane Sandy - Northeastern United States, 2012. MMWR Morb Mortal Wkly Rep. 2012 Nov 9;61(44):905. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6144a5.htm?s_cid=mm6144a5_w 8. Graber JM, Smith AE. Results from a state-based surveillance system for carbon monoxide poisoning. Public Health Rep. 2007 Mar-Apr;122(2):145-54. http://www.publichealthreports.org/issueopen.cfm?articleID=1811 9. Spiller HA, Griffith JR. The value and evolving role of the U.S. Poison Control Center System. Public Health Rep. 2009 May-Jun;124(3):359-63. http://www.publichealthreports.org/issueopen.cfm?articleID=2197 10. Bekkedal M, Sipsma K, Stremski ES, Malecki KC, Anderson HA. Evaluation of five data sources for inclusion in a statewide tracking system for accidental carbon monoxide poisonings. WMJ. 2006 Mar;105(2):36-40. https://www.wisconsinmedicalsociety.org/_WMS/publications/wmj/pdf/105/2/36.pdf 11. Schier JG. Poison Control Centers and Toxicosurveillance: Real-time National Surveillance for Outbreaks of Chemical-Associated Illness. Presented May 2008 to CDC Emergency Preparedness & Response COCA conference call. http://www.bt.cdc.gov/coca/ppt/PoisonControl%20CentersToxicosurveillance_052008_FINAL.ppt 12. Wolkin AF, Martin CA, Law RK, Schier JG, Bronstein AC. Using poison center data for national public health surveillance for chemical and poison exposure and associated illness. Ann Emerg Med. 2012 Jan;59(1):56-61. 13. Hampson NB, Piantadosi CA, Thom SR, Weaver LK. Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am J Respir Crit Care Med. 2012 Dec 1;186(11):1095-101. 14. Ball LB, Macdonald SC, Mott JA, Etzel RA. Carbon monoxide-related injury estimation using ICD-coded data: methodologic implications for public health surveillance. Arch Environ Occup Health. 2005 May-Jun;60(3):119-27. XI. Coordination Agencies for Response (List only one name per agency, preferably an individual in a senior management position; complete contact information must be provided for acceptance to review.) (1) CDC Agency
Contact Full Name
Title
Address Line 1
Address Line 2 City, State and Zip Telephone Number Email Address (2) Agency
Contact Full Name
Title
Address Line 1
Address Line 2 City, State and Zip Telephone Number Email Address (3) Agency
Contact Full Name
Title
Address Line 1
Address Line 2 City, State and Zip Telephone Number Email Address *For additional Agencies for Response, please provide a separate attachment with complete contact information. Agencies for Information: (Complete contact information must be provided for acceptance to review.) (1) AAPCC Agency
Contact Full Name
Title
Address Line 1
Address Line 2 City, State and Zip Telephone Number Email Address (2) Agency
Contact Full Name
Title
Address Line 1
Address Line 2 City, State and Zip Telephone Number Email Address (3) Agency
Contact Full Name
Title Address Line 1 Address Line 2 City, State and Zip Telephone Number Email Address *For additional Agencies for Information, please provide a separate attachment with complete contact information. XII. Submitting Author: (Must be an Active CSTE Member and complete contact information provided for acceptance to review.) (1) Steven C. Macdonald Contact Full Name
Title
Agency Address Line 1 Address Line 2 City, State and Zip Telephone Number Email Address Co-Author: (Complete contact information must be provided for acceptance to review.) (1)
Contact Full Name
Title Agency
Address Line 1
Address Line 2 City, State and Zip Telephone Number Email Address (2)
Contact Full Name
Title Agency
Address Line 1
Address Line 2 City, State and Zip Telephone Number Email Address *For additional Authors, please provide a separate attachment with complete contact information. Table VI-B. Table of criteria to determine whether a case should be reported to public health authorities.
Notes: Each alternative disease or condition subtype is listed in a separate column. Each criterion (symptom, sign, lab result, immunization status, occupation, travel history, etc.) is listed in a separate row. Meeting the criteria listed under any single column of this table is sufficient to identify a case for reporting. [Change the generic “Disease or condition subtype” language to the appropriate term, which can be a clinical distinction (e.g., cutaneous anthrax, inhalational anthrax), or an agent (e.g., a type of arbovirus), or a route of exposure (e.g., foodborne botulism, wound botulism). Delete unnecessary columns. Use letter codes provided. Where the action of ordering a laboratory test meets a criterion for reporting, indicate by use of asterisk.] S = This criterion alone is Sufficient to report a case. N = All “N” criteria in the same column are Necessary to report a case. O = At least one of these “O” (Optional) criteria in each category (e.g., clinical evidence and laboratory evidence) in the same column—in conjunction with all “N” criteria in the same column—is required to report a case. (These optional criteria are alternatives, which means that a single column will have either no O criteria or multiple O criteria; no column should have only one O.) * A requisition or order for any of the “S” laboratory tests is sufficient to meet the reporting criteria. Table VII-B. Criteria for defining a case of [condition]. NOTE: Please remember to incorporate the criteria specified in Section VII above titled “Criteria to distinguish a new case of this disease or condition from reports or notifications which should not be enumerated as a new case for surveillance,” which should be considered in determining whether to count this as a new case. This section is not applicable if not relevant to the condition.
Notes: Each criterion (symptom, sign, lab result, immunization status, occupation, travel history, etc.) is listed in a separate row. Meeting the criteria listed under any single column of this table is sufficient to classify a case. [Use letter codes provided.] S = This criterion alone is Sufficient to classify a case. N = All “N” criteria in the same column are Necessary to classify a case. A number following an “N” indicates that this criterion is only required for a specific disease/condition subtype (see below). A = This criterion must be absent (i.e., NOT present) for the case to meet the classification criteria. O = At least one of these “O” (Optional) criteria in each category (e.g., clinical evidence and laboratory evidence) in the same column—in conjunction with all “N” criteria in the same column—is required to classify a case. (These optional criteria are alternatives, which means that a single column will have either no O criteria or multiple O criteria; no column should have only one O.) A number following an “O” indicates that this criterion is only required for a specific disease/condition subtype. [Use the following numbers to indicate different disease/condition subtypes (e.g., cutaneous anthrax vs. inhalational anthrax; type of arbovirus; foodborne botulism vs. wound botulism); delete if not needed.] 1 = 2 =
3 = 4 =
Appendix. Examples of types of information that could be used for criteria to distinguish a new case from duplicates, recurrence, persistent state, carrier state, acute versus chronic state, recrudescence, and relapse. (a) time periods between repeated lab results for the same pathogen or environmental hazard --Note: It may be useful to define a hierarchy of dates to consider for the starting point for the repeated measures, since some dates may not be available to surveillance staff; (b) sites of infection; (c) exposure and travel history as it relates to dates of illness onset, diagnosis, lab tests, or hospitalization; and (d) whether the condition was successfully treated. CSTE National Office Staff can provide examples of criteria used by health jurisdictions and CDC programs. Appendix 1: ICD codes
Legend: The table above is a supplement to Table VII, and should not be used independently of Table VII.
Legend: The table above is a supplement to Table VII, and should not be used independently of Table VII.
Legend: The table above is a supplement to Table VII, and should not be used independently of Table VII. 1 Use only for diseases that are not healthcare-associated infections (HAI) reported through NHSN. For HAI, use the Template for Placing Healthcare-Associated Diseases or Conditions Under National Surveillance through the National Healthcare Safety Network. Council of State and Territorial Epidemiologists Position Statement Template: Standardized Surveillance for Diseases or Conditions, Revised 2013 Directory: resource -> dynamic -> forums resource -> Occupational health and safety resource -> Practice learning resource -> The Rise of Video Games Section “Word” Matt Spencer resource -> Request for proposal contract form for the transit industry resource -> Request for Proposal [insert date] resource -> Biblical Eschatology Presentation by: D. Paul Beck May 4, 2016 Ground Rules resource -> The University of York 13th 16th April 2004 resource -> Biological and Biomedical Sciences Program Community Education Initiative forums -> Iaap convention & Annual Meeting sites year District City/State Convention Facility Download 356.89 Kb. Share with your friends:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||